The DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.
Serum matrix metalloproteinase 3 is an independent predictor of structural damage progression in patients with ankylosing spondylitis
Abstract
Objective: In prospective studies, only baseline radiographic damage has been identified as an independent predictor of radiographic progression in ankylosing spondylitis (AS). Several biomarkers have been identified as independent predictors of radiographic progression in rheumatoid arthritis, however, and these may be of use in AS. This study was undertaken to analyze serologic biomarkers as predictors of radiographic progression in AS. Methods: We measured a panel of biomarkers reflecting cartilage turnover and osteoclasis. These biomarkers were cartilage oligomeric matrix protein, human cartilage gp‐39 (YKL‐40), type II collagen epitopes detected by the C2C and C1,2C degradation assays and the CPII synthesis assay, aggrecan 846 epitope, osteoprotegerin, and matrix metalloproteinase 3 (MMP‐3). The analysis was performed in a cohort of AS patients from the Netherlands, Belgium, and France enrolled in a longitudinal study, the Outcome Assessments in Ankylosing Spondylitis International Study. We examined 2‐year radiographic progression data scored using the modified Stoke AS Spine Score (mSASSS). Results: Complete data were available on 97 patients. Only the biomarkers YKL‐40 and MMP‐3 showed weak to moderate univariate correlation with 2‐year progression. After adjustment for sex, age, disease duration, C‐reactive protein level, and baseline mSASSS, only MMP‐3 was significantly associated with 2‐year progression (β = 0.29, P = 0.004). Logistic regression analysis revealed MMP‐3 (cutoff 68 ng/ml; odds ratio 9.4 [95% confidence interval 1.6–56]) and baseline mSASSS (cutoff 10 mSASSS units; odds ratio 18.6 [95% confidence interval 2.5–138]) as the only independent predictors of 2‐year progression (cutoff 3 mSASSS units; model R 2 = 50%). MMP‐3 was primarily contributory in patients who already had substantial baseline damage (>10 mSASSS units). Conclusion: These results indicate that MMP‐3 is a significant independent predictor of radiographic progression in patients with AS, particularly in those with preexisting radiographic damage.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Geusens, P. P., Landewé, R. B. M., Garnero, P., Chen, D., Dunstan, C. R., Lems, W. F., Stinissen, P., van der Heijde, D. M. F. M., van der Linden, S., & Boers, M. (2006) · Arthritis & Rheumatism · doi:10.1002/art.21896 · Cited by 182
Self-citation
Cited by
Sieper, J., & Poddubnyy, D. (2017) · The Lancet · doi:10.1016/s0140-6736(16)31591-4 · Cited by 1,333
Mandl, P., Navarro-Compán, V, Terslev, L., Aegerter, P., van der Heijde, D., D'Agostino, M. A., Baraliakos, X., Pedersen, S. J., Jurik, A. G., Naredo, E., et al. (2015) · Annals of the Rheumatic Diseases · doi:10.1136/annrheumdis-2014-206971 · Cited by 572
Self-citationvan der Heijde, D., Landewé, R., Einstein, S., Ory, P., Vosse, D., Ni, L., Lin, S. ‐., Tsuji, W., & Davis, J. C. (2008) · Arthritis & Rheumatism · doi:10.1002/art.23471 · Cited by 549
Self-citationvan der Heijde, D., Salonen, D., Weissman, B. N., Landewé, R., Maksymowych, W. P., Kupper, H., Ballal, S., Gibson, E., Wong, R., & the Canadian (M03-606) study group and the ATLAS study group (2009) · Arthritis Research & Therapy · doi:10.1186/ar2794 · Cited by 413
Self-citation
Metadata
- Authors
- Maksymowych, W. P., Landewé, R., Conner‐Spady, B., Dougados, M., Mielants, H., van der Tempel, H., Poole, A. R., Wang, N., & van der Heijde, D.
- Venue
- Arthritis & Rheumatism
- Publisher
- Wiley
- Published
- 2007-05-25
- Volume
- 56
- Issue
- 6
- Pages
- 1846-1853
- ISSN
- 0004-3591 (ISSN-L)
- 1529-0131
- OpenAlex
- W1965690582
- Cited by
- 164
- References
- 1
- FWCI
- 8.27
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Serum matrix metalloproteinase 3 is an independent predictor of structural damage progression in patients with ankylosing spondylitis. https://app.cochat.ai/papers/10.1002/art.22589
- The paper
- Maksymowych, W. P., Landewé, R., Conner‐Spady, B., Dougados, M., Mielants, H., van der Tempel, H., Poole, A. R., Wang, N., & van der Heijde, D. (2007). Serum matrix metalloproteinase 3 is an independent predictor of structural damage progression in patients with ankylosing spondylitis. Arthritis & Rheumatism. https://doi.org/10.1002/art.22589
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.